Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment.
D000336:Aerosols; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000032:analysis*; D001228:Aspergillosis / Q000188:drug therapy* / Q000276:immunology*; D001230:Aspergillus / Q000145:classification / Q000276:immunology; D001982:Bronchial Diseases / Q000188:drug therapy* / Q000276:immunology*; D002648:Child; D005260:Female; D000882:Haplorhini / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000032:analysis; D007275:Injections, Intravenous; D008172:Lung Diseases, Fungal / Q000188:drug therapy* / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use
D000336:Aerosols; D000906:Antibodies; D007074:Immunoglobulin G; D000666:Amphotericin B; D011241:Prednisone